Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation
Lead and deliver model-informed drug development (MIDD) strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize clinical trial design, dose selection, and regulatory submissions. Work across multidisciplinary teams to advance GSK’s oncology pipeline using quantitative approaches including exposure-response modeling, disease progression models, and simulation-based trial design. Drive innovation through external collaborations, publications, and adoption of cutting-edge methodologies in clinical pharmacology.